ASIC Corporations (Short Selling) Instrument 2018/745
made under subsection 1020F(1) of the Corporations Act 2001
Compilation No.5
Compilation date: 03 February 2026
Includes amendments up to: ASIC Corporations (Amendment) Instrument 2026/24 (F2026L00061)
About this compilation
This compilation
This is a compilation of the ASIC Corporations (Short Selling) Instrument 2018/745 that shows the text of the law as amended and in force on 03/02/2026 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au).
Application, saving and transitional provisions
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. Any modifications affecting the law are accessible on the Register.
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Self-repealing provisions‑repealing provisions
1 Name of legislative instrument
Part 2—Short selling exemptions: market participants
5 Market makers: exchange traded funds and specified structured products
6 Market makers: Bona fide hedging
7 Exchange traded options: sales effected by exercising options
8 Exchange traded options: other scenarios
9 Debentures: Clearing and settlement participants
10 Deferred purchase agreements
Part 3—Short selling exemptions: capital markets
11 Deferred settlement trading arrangements on licensed markets
12 Initial public offers: Sale offers through special purpose vehicles
Part 4—Exemptions from short selling reporting
13 Market makers: exchange traded funds and specified structured products
14 Market makers: bona fide hedging
15 Low volume and low value short positions
Part 5—Definitional and other changes
17 Short position reporting and short sale transaction reporting
This is the ASIC Corporations (Short Selling) Instrument 2018/745.
This instrument is made under subsection 1020F(1) of the Corporations Act 2001.
In this instrument:
Act means the Corporations Act 2001.
Regulations means the Corporations Regulations 2001.
Section 1020B products has the meaning given by subsection1020B(1) of the Act.
Part 7.9 of the Act applies in relation to section 1020B products as if section 1020B of the Act were modified or varied by, after subsection (4), inserting the following subsections:
Market makers: exchange traded funds and specified structured products
(4A) Subsection (2) does not apply to an ETP market maker in relation to a sale of:
(a) interests (the shorted product) in, or securities (the shorted product) of, an exchange traded fund; or
(b) securities (the shorted product) that are specified structured products;
by the ETP market maker where both of the following are satisfied:
(c) the sale occurs on a day where the operator of the fund, the company or the foreign company (as applicable) allows applications for and redemptions of interests or securities in the same class as the shorted product;
(4B) The ETP market maker must:
(a) before engaging in conduct in first reliance on subsection (4A), give a notice of reliance to ASIC;
(b) before making an offer to sell the shorted product, keep a record that states that the proposed sale will be a short sale, and preserve the record for 12 months after the day on which the last entry was made in the record;
(c) as soon as reasonably practicable after the sale of the shorted product but before the time for delivery of the shorted product, acquire or apply for a sufficient number of financial products in the same class as the shorted product to enable the ETP market maker to fulfil their delivery obligations under the sale;
(d) if the sales of shorted products by the market maker in reliance on subsection (4A) during a reporting period exceeds the settlement failure limit—give a settlement failure notice to ASIC within 28 days after the end of the reporting period;
(e) if the relevant market operator has given a notice of suspension or cancellation to the ETP market maker—give a copy of the notice to ASIC within 28 days of receiving the notice;
(f) if the operator of the scheme, the company or the foreign company has given a notice of suspension or cancellation to the ETP market maker in relation to the exchange traded fund or specified structured product—give a copy of the notice to ASIC within 28 days of receiving the notice;
(g) if the ETP market maker no longer seeks to rely on subsection (4A) in relation to an exchange traded fund or a specified structured product or a class of exchange traded funds or specified structured products—give a notice of cessation to ASIC.
(4C) Subsection (4A) does not apply to an ETP market maker in relation to an exchange traded fund or a specified structured product if ASIC has given a notice of exclusion to the ETP market maker and has not withdrawn it.
(4D) In subsections (4A) to (4C):
(a) exchange traded fund (or ETF) means a scheme or foreign company that satisfies all of the following:
(a) is:
(i) a registered scheme or a managed investment scheme that is not required to be registered under Chapter 5C; or
(ii) a foreign company which has the economic features of a managed investment scheme and is an open-ended investment company registered with the U.S. Securities and Exchange Commission under the Investment Company Act 1940 of the United States of America;
(b) interests in the scheme or securities of the foreign company are in a class that are able to be traded on a declared financial market operated in this jurisdiction;
(c) the operator of the scheme or the foreign company has the power and approval to issue interests or securities in that class on any day that those interests or securities are able to be traded on the financial market;
(d) the operator of the scheme or the foreign company allows applications for and redemptions of interests or securities in that class;
(e) the price or value of the financial product, index, currency, commodity or other thing that the scheme or foreign company invests in or tracks is continuously disclosed or can be immediately ascertained.
ETP (or exchange traded product) means an exchange traded fund or a specified structured product.
ETP market maker, in relation to interests in, or securities of, an exchange traded fund or securities that are specified structured products, where the interests or securities are able to be traded on a declared financial market operated in this jurisdiction, means a person who:
(a) holds an Australian financial services licence that covers making a market in the interests or securities or is exempt from the requirement to hold such a licence for providing that financial service; and
(b) either has:
(i) entered into an agreement with the relevant market operator; or
(ii) demonstrated to the relevant market operator that it has been appointed by the operator of the scheme, company or foreign company;
to make a market for those interests or securities.
notice of exclusion, in relation to an ETP market maker, means a notice specifying that the ETP market maker is excluded from relying on subsection (4A) in relation to an exchange traded fund or a specified structured product or a class of exchange traded funds or specified structured products.
notice of reliance, in relation to an ETP market maker, means a notice that:
(a) states that the ETP market maker intends to rely on subsection (4A) to make short sales of interests in, or securities of, exchange traded funds or specified structured products in the course of making a market in those interests or securities; and
(b) includes the name, and unique code assigned by the relevant market operator, for each exchange traded fund and specified structured product to which the notice relates.
Note: A new notice of reliance must be given to ASIC if the ETP market maker wishes to rely on subsection (4A) in relation to an exchange traded fund or a specified structured product that was not included in an earlier notice of reliance.
notice of suspension or cancellation, in relation to an ETP market maker, means a notice that has the effect of suspending or cancelling:
(a) the agreement with the relevant market operator; or
(b) the appointment by the operator of the scheme, company or the foreign company;
for the ETP market maker to make a market for interests in, or securities of:
(c) an exchange traded fund or a specified structured product; or
(d) a class of exchange traded funds or specified structured products.
precious metal means each of gold, silver, platinum and palladium.
reporting period means a 12-month period commencing on 1 April of any given year and ending on 31 March in the following year.
settlement failure limit, in relation to an ETP market maker, means 1% of the volume or value of the sales by the ETP market maker during a reporting period in reliance on subsection (4A) that have failed to settle within the time period required under the relevant operating rules of the relevant market.
settlement failure notice, in relation to an ETP market maker, means a notice setting out the volume and value of the sales by the ETP market maker during a reporting period in reliance on subsection (4A) that have failed to settle within the time period required under the relevant operating rules of the relevant market.
specified structured product means a security in relation to which the following apply:
(a) the security is in a class that is able to be traded on a declared financial market operated in this jurisdiction, is admitted to trading status as a structured product on that market and is not an interest or a security in an ETF;
(b) the security is issued by a company that has the power and approval to issue the security in that class on any day that the securities are able to be traded on the financial market;
(c) the company allows applications for and redemptions of securities in that class;
(d) the value of the security (other than to a nominal extent) derives from the value of one or more precious metals that are held on trust for the holder of the security;
(e) the holders of securities do not have the day-to-day control over the operation of the company which issues the security.
(b) for the avoidance of doubt, paragraph (4B)(d) applies to an ETP market maker in relation to a reporting period even if the ETP market maker stopped relying on subsection (4A) during the reporting period because of a notice of cessation or a notice of exclusion.”.
Part 7.9 of the Act applies in relation to section 1020B products as if section 1020B of the Act were modified or varied by, after subsection (4), inserting the following subsections:
“Market makers: bona fide hedging
(5A) Subsection (2) does not apply to a market maker in relation to a sale of a security (the shorted product) or managed investment product (the shorted product) by the market maker where all of the following apply:
(a) the market maker has issued, acquired or disposed of a financial product (the hedged product), or has agreed to issue, acquire or dispose of a financial product (the hedged product), in the course of making a market for the hedged product;
(b) the sale of the shorted product is a bona fide transaction to manage, avoid or limit the financial consequences of the dealing or proposed dealing mentioned in paragraph (a);
(c) at the time of the sale, the shorted product is:
(i) a constituent of the index known as the S&P/ASX 300; or
(ii) an interest in the SPDR S&P/ASX 200 Fund (STW); or
(iii) a security that is an approved ETP or an interest in an approved ETP, where:
(A) the hedged product is an approved ETO in relation to that ETP; and
(B) the market maker has been appointed to make a market in the approved ETO by the operator of the market that the approved ETO is admitted to trading on;
Note: The S&P/ASX 300 index is compiled and calculated by S&P Dow Jones Indices LLC, a division of S&P Global, Inc. Its constituents are subject to change from time to time. Details of the current constituents may be found via www.spglobal.com.
(5B) The market maker must only engage in the conduct covered by and in reliance on subsection (5A) if, at the time of the sale, the market maker believes on reasonable grounds that either:
(a) for any shorted product—before the time for delivery of the shorted product, a securities lending arrangement in relation to financial products in the same class as the shorted product can be put in place so that the shorted product can be unconditionally vested in a buyer by the time for delivery; or
(b) for a shorted product that is:
(i) an interest in STW; or
(ii) an interest in an approved ETP; or
(iii) a security that is an approved ETP;
before the time for delivery of the shorted product, the market maker can acquire or apply for a sufficient number of interests in STW, interests in the approved ETP or securities that are the approved ETP so that the shorted product can be unconditionally vested in a buyer by the time for delivery.
(5C) The market maker must do at least one of the following things by the end of the day (sale day) on which the market maker makes the sale of the shorted product in reliance on subsection (5A) so that the shorted product can be unconditionally vested in a buyer by the time for delivery:
(a) for any shorted product—have acquired a financial product in the same class as the shorted product; or
(b) for any shorted product—have entered into a contract to buy a financial product in the same class as the shorted product where the market maker has a right to have that financial product vested in the market maker that is conditional only upon all or any of the following:
(A) payment of the consideration in respect of the purchase;
(B) the receipt by the market maker of a proper instrument of transfer in respect of the product;
(C) the receipt by the market maker of the documents that are, or are documents of title to, the product; or
(c) for any shorted product—have entered into a securities lending arrangement in relation to financial products in the same class as the shorted products; or
(d) for a shorted product that is an interest in STW, an interest in an approved ETP or a security that is an approved ETP—have acquired or applied for interests in STW, interests in the approved ETP or securities that are the approved ETP.
(5D) A market maker that fails to comply with subsection (5C) must notify ASIC in writing of the failure by no later than 9 am in Sydney, New South Wales on the next business day after the sale day.
(5E) The market maker must give to ASIC in the form required by ASIC particulars of the person’s short position in relation to the shorted product as at:
(a) where the nominated time is, or corresponds to a time that is, on or before 11:59 pm in Sydney, New South Wales—the nominated time 3 reporting days before the day the particulars must be given under subsection (5F); and
(b) otherwise—the nominated time 2 reporting days before the day the particulars must be given under subsection (5F); and
(5F) The market maker must give the particulars about the short position:
(a) where the nominated time is, or corresponds to a time that is, on or before 11:59 pm in Sydney, New South Wales—on or before 9 am in Sydney, New South Wales on the third reporting day after entering into the agreement to sell that causes the short position to occur;
(b) otherwise—on or before 9am in Sydney, New South Wales on the second reporting day after entering into the agreement to sell that causes the short position to occur; and
(c) in either case—on or before 9 am in Sydney, New South Wales on each subsequent reporting day as long as the market maker has a short position.
(5G) Paragraph (5F)(c) applies whether or not the particulars about the short position have changed from that given on the previous day.
(5H) The market maker does not have to comply with subsection (5G) in relation to that short position if the market maker:
(a) is required by subsection 1020AB(3) to give particulars of the market maker’s short position on a day in relation to a security or product that is in the same class as the shorted product; or
(b) has a short position in relation to the shorted product on a day that does not exceed the value limit and the volume limit on the day.
(5J) In subsections (5A) to (5H):
approved ETP means each of:
(a) the Vanguard MSCI Index International Shares ETF; and
(b) the iShares Core S&P 500 ETF; and
(c) the Betashares NASDAQ 100 ETF; and
(d) the Global X Physical Gold Structured.
approved ETO means an exchange traded option that is exercisable:
(a) only on one specific date; and
(b) in respect of an interest in an underlying approved ETP.
ETO (or exchange traded option) means an option registered with:
(a) ASX Clear Pty Limited; or
(b) ASX Clear (Futures) Pty Limited.
ETP (or exchange traded product) has the same meaning as in subsection 1020B(4D).
Part 7.9 of the Act applies in relation to section 1020B products as if section 1020B of the Act were modified or varied by, after subsection (4), inserting the following subsections:
“Exchange traded options: sales effected by exercising options
(6A) Subsection (2) does not apply to a person (option holder) that holds an option registered with ASX Clear Pty Limited in relation to a sale of a security (the shorted product) or managed investment product (the shorted product) where the transaction effecting the sale of the shorted product is the result of the exercise of the option by the option holder.
(a) where the nominated time is, or corresponds to a time that is, on or before 11:59 pm in Sydney, New South Wales—the nominated time 3 reporting days before the day the particulars must be given under subsection (6C); and
(b) otherwise—the nominated time 2 reporting days before the day the particulars must be given under subsection (6C).
(6C) The option holder must give the particulars about the short position:
(a) where the nominated time is, or corresponds to a time that is, on or before 11:59 pm in Sydney, New South Wales—on or before 9 am in Sydney, New South Wales on the third reporting day after the exercise of the option that causes the short position to occur;
(b) otherwise—on or before 9 am in Sydney, New South Wales on the second reporting day after the exercise of the option that causes the short position to occur; and
(c) in either case—on or before 9 am in Sydney, New South Wales on each subsequent reporting day as long as the holder has a short position.
(6D) Paragraph (6C)(c) applies whether or not the particulars about the short position have changed from that given on the previous day.
(6E) The option holder does not have to comply with subsection (6B) in relation to that short position if the holder:
(a) is required by subsection 1020AB(3) to give particulars of the holder’s short position on a day in relation to a security or product that is in the same class as the shorted product; or
(b) has a short position in relation to the shorted product on a day that does not exceed the value limit and the volume limit on the day.”.
(1) A person does not have to comply with subsection 1020B(2) of the Act in relation to a sale of section 1020B products that is done by issuing or selling an exchange traded option on a financial market.
(2) A person does not have to comply with subsection 1020B(2) of the Act in relation to a sale of unobtained section 1020B products if the person (or, where the person is selling as an agent, the principal) is, at the time of the sale, able to obtain at least the number of section 1020B products of the same class as the unobtained section 1020B products by exercising exchange traded options.
(3) For the purposes of subsection (2):
(a) the number of section 1020B products of a class that a person is able to obtain at the time of a sale is to be calculated according to the following formula:
FPIO – FPSO – PS
where:
FPIO (Financial Products Immediately Obtainable) means the number of section 1020B products of the class that, at the time of the sale, the person is able to obtain by exercising exchange traded options at a price:
(a) that does not exceed the sale price payable to the person under the sale; or
(b) that exceeds the sale price by an amount that is no more than an amount deposited by the person with:
(i) ASX Clear Pty Limited; or
(ii) ASX Clear (Futures) Pty Limited;
before and in relation to the sale;
FPSO (Financial Products Subject to Options) means the number of section 102B products of the class sold over which the person has issued exchange traded options which would oblige the person to deliver the products if the options were exercised and that, at the time of sale, have not expired or been exercised;
PS (unobtained financial products Previously Sold) means the number of unobtained section 1020B products previously sold in sales that have not been completed at the time of the sale; and
(b) the price payable by the person for obtaining section 1020B products by exercising exchange traded options is to be calculated by reference first to the option with the lowest exercise price, then to the option with the second lowest exercise price, and so on in ascending order of price until the necessary number of options would have been exercised.
(4) In this section:
exchange traded option has the same meaning as in subsection 1020B(5J) of the Act.
Note: Subsection 1020B(5J) of the Act is notionally inserted by section 6 of this instrument.
unobtained section 1020B products means section 1020B products of a class:
(a) that a person has agreed to sell; and
(b) in relation to which the person (or where the person is selling as an agent, the principal) does not, at the time of the sale, have a presently exercisable and unconditional right to vest in a buyer.
(1) A person that is entitled to use the clearing and settlement facilities of a CS facility licensee or the Reserve Bank Information and Transfer System does not have to comply with subsection 1020B(2) of the Act in relation to a sale of eligible debentures where the person:
(a) sells the debentures as principal; and
(b) believes on reasonable grounds that arrangements can be put in place before the time for delivery of the debentures that will enable the debentures to be unconditionally vested in a buyer by the time for delivery.
(2) In this section:
eligible debentures mean:
(a) bonds issued by a government; or
(b) debentures or bonds of a body corporate if the value of debentures or bonds on issue with the same maturity and coupon terms exceeds $100,000,000.
(1) A person who agrees to sell section 1020B products under a deferred purchase agreement does not have to comply with subsection 1020B(2) of the Act in relation to the sale.
(2) In this section:
deferred purchase agreement means an agreement to sell securities (delivery products) or managed investment products (delivery products) that are able to be traded on a declared financial market operated in this jurisdiction, under which:
(a) a person agrees to deliver, at least 12 months after entering into the agreement, delivery products at a specified time (maturity) in the future to another person; and
(b) the number and value of the delivery products to be delivered at maturity is ultimately determined or derived from the value or amount of one or more of the following:
(i) other financial products (other than a derivative that relates to the delivery products);
(ii) an asset;
(iii) a rate (including an interest rate or exchange rate);
(iv) an index;
(v) a commodity; and
(c) the person who agrees to deliver the delivery products at maturity has the right, in circumstances set out in the agreement, to instead deliver other securities or managed investment products where the securities or products are, at maturity, in a class of financial products that is a constituent of the index known as the S&P/ASX 200.
Note: This index is compiled and calculated by S&P Dow Jones Indices LLC,, a division of S&P Global Inc. Its constituents are subject to change from time to time. Details of the current constituents may be found via www.spglobal.com.
Part 7.9 of the Act applies in relation to section 1020B products as if section 1020B of the Act were modified or varied by, after subsection (4), inserting the following subsections:
“Public offers—conditional deferred settlement trading arrangements
(7A) Subsections (7B) to (7F) apply to a sale of section 1020B products on a licensed market, during a deferred settlement trading period, in relation to a public offer.
(7B) A person must only, in this jurisdiction, sell section 1020B products to a buyer on a licensed market during a deferred settlement trading period if, at the time of the sale:
(a) the person has or, if the person is selling on behalf of another person, that other person has; or
(b) the person believes on reasonable grounds that the person has or, if the person is selling on behalf of another person, that other person has;
an entitlement to be issued with or sold the products under or in connection with a public offer.
(7C) A person has an entitlement to be issued with section 1020B products under or in connection with a public offer if:
(a) before the commencement of the deferred settlement trading period:
(i) the products are offered for issue under a prospectus, pathfinder prospectus or Product Disclosure Statement (each the offer document) in connection with either:
(A) the proposed listing of a listing body or listing scheme; or
(B) the proposed admission to quotation of the products in relation to a listed corporation; and
(b) the products are to be issued to applicants under the offer document subject only to all or any of the following:
(i) completion of any agreement between the listing body (or the responsible entity of the listing scheme) and underwriters or other participants involved in the proposed listing in accordance with its terms, as disclosed in the offer document;
(ii) completion of any corporate restructure, or corporate transaction (including acquisitions or divestments), by the listing body (or the responsible entity of the listing scheme) or a related body corporate, as disclosed in the offer document;
(iii) the decision of the listing body (or responsible entity of the listing scheme) or listed corporation to issue the products to applicants under the offer document.
(7D) A person has an entitlement to be sold section 1020B products under or in connection with a public offer if:
(a) before the commencement of the deferred settlement trading period:
(i) the products are offered for sale by a person (the sale offeror) under a prospectus, pathfinder prospectus or Product Disclosure Statement (each the offer document) in connection with the proposed listing of a listing body or listing scheme; and
(ii) the listing body (or the responsible entity of the listing scheme) makes an offer of section 1020B products for issue under the offer document that are in the same class as the products offered by the sale offeror; and
(iii) the person made an application, including payment of (or an agreement to pay) application monies, to acquire the products from the sale offeror under or in connection with the offer document; and
(b) the products are to be sold by the sale offeror to applicants under the offer document subject only to all or any of the following as applicable:
(i) completion of any agreement between the listing body (or the responsible entity of the listing scheme) and underwriters or other participants involved in the proposed listing in accordance with its terms, as disclosed in the offer document;
(ii) completion of any corporate restructure, or corporate transaction (including acquisitions or divestments), by the listing body (or the responsible entity of the listing scheme) or a related body corporate, as disclosed in the offer document;
(iii) completion of the transfer of the products to the sale offeror, as disclosed in the offer document;
(iv) the sale offeror’s decision to transfer the products to applicants under the offer document;
(v) all or any of the matters specified in paragraphs (4)(a), (b) or (c); or
(7E) Subsections (2) and (7B) do not apply in relation to a sale of section 1020B products on a licensed market during a deferred settlement trading period:
(a) by a person who, during the deferred settlement trading period but before the time of the sale, has entered into a contract on the market to buy the products; or
(b) by a person selling on behalf of the person mentioned in paragraph (a) in the circumstances covered by that paragraph.
(7F) For the purposes of subsections (7A) to (7E):
(a) nothing in those subsections limits the generality of anything else in any of them;
(b) deferred settlement trading arrangements, in relation to a public offer of section 1020B products, means arrangements determined by the operator of a declared financial market operated in this jurisdiction in accordance with the operating rules of the financial market, under which the trading of section 1020B products in relation to the public offer may be conditional and the settlement of sales of those products is deferred according to a timetable published by the operator.
deferred settlement trading period, in relation to a public offer, means a period determined by the operator of a declared financial market operated in this jurisdiction in accordance with the operating rules of the financial market, during which deferred settlement trading arrangements apply in relation to the public offer.
listing body means a body corporate that is seeking to become a listed corporation.
listing scheme means a registered scheme that is seeking to become a listed registered scheme.
pathfinder prospectus means a draft prospectus sent to a person in the circumstances covered by subsection 734(9).
public offer means:
(a) a proposed issue or sale of section 1020B products in relation to a proposed listing of a listing body or listing scheme on a declared financial market operated in this jurisdiction; or
(b) a proposed issue of section 1020B products in relation to a proposed admission to quotation of the products in relation to a listed corporation or a listed registered scheme.
Corporate actions—deferred settlement trading arrangements
(7G) Subsections (7H) to (7J) apply to a sale of section 1020B products on a licensed market, during a deferred settlement trading period, in relation to a corporate action.
(a) the person is or, if the person is selling on behalf of another person, that other person is; or
(b) the person believes on reasonable grounds that the person is or, if the person is selling on behalf of another person, that other person is;
in a class of persons who, because such persons hold financial products of a particular class, have an entitlement to be issued with or transferred the section 1020B products under or in connection with the corporate action.
(7I) Subsections (2) and (7H) do not apply in relation to a sale of section 1020B products on a licensed market during a deferred settlement trading period:
(a) by a person who, during the deferred settlement trading period but before the time of the sale, has entered into a contract on the market to buy the products; or
(b) by a person selling on behalf of the person mentioned in paragraph (a) in the circumstances covered by that paragraph.
(7J) For the purposes of subsections (7G) to (7I):
corporate action means a proposed issue of section 1020B products under or in connection with:
(a) a compromise or arrangement under Part 5.1;
(b) a rights issue;
(c) a dividend or distribution reinvestment plan;
(d) a bonus issue;
(e) a conversion of convertible notes or convertible securities;
(f) a conversion of shares under section 254H.
deferred settlement trading arrangements, in relation to a corporate action, means arrangements determined by the operator of a declared financial market operated in this jurisdiction in accordance with the operating rules of the financial market, under which the settlement of sales of section 1020B products in relation to the corporate action is deferred according to a timetable published by the operator.
deferred settlement trading period, in relation to a corporate action, means a period determined by the operator of a declared financial market operated in this jurisdiction in accordance with the operating rules of the financial market, during which deferred settlement trading arrangements apply in relation to the corporate action.
(1) A body (the special purpose body) does not have to comply with subsection 1020B(2) of the Act in relation to a sale of shares in a body (the listing body) by the special purpose body where all of the following are satisfied:
(a) the sale of the shares is made under a prospectus or pathfinder prospectus or both in connection with the proposed listing of the listing body on a declared financial market operated in this jurisdiction;
(b) at the time of the sale, an agreement exists between the special purpose body and a person (the selling shareholder) who has a presently exercisable and unconditional right to vest the shares in a buyer;
(c) under the agreement the selling shareholder agrees to sell the shares to the special purpose body (or its nominee) and the special purpose body agrees to purchase (or agrees to procure its nominee to purchase) the shares from the selling shareholder, on the condition that the listing body is included in the official list of the financial market and the shares are admitted to quotation on that market;
(d) at the time of the sale, the special purpose body is not selling the shares on behalf of the selling shareholder;
(e) the listing body makes offers to issue shares which are in the same class as the shares offered for sale by the special purpose body, under either:
(i) if the special purpose body is selling the shares under a prospectus (whether or not it is also selling the shares under a pathfinder prospectus)—the prospectus; or
(ii) if the special purpose body is selling the shares under a pathfinder prospectus (and not also under a prospectus)—a prospectus.
(2) In subsection (1):
pathfinder prospectus means a draft prospectus sent to a person in the circumstances covered by subsection 734(9) of the Act.
(1) An ETP market maker does not have to comply with subsection 1020AB(3) of the Act to the extent it requires the ETP market maker to give the particulars specified in paragraphs 7.9.100(1)(a) to (c) of the Regulations.
(2) Subsection (1) applies in relation to a sale of:
(a) interests in, or securities of, an exchange traded fund; or
(b) securities that are specified structured products;
by the ETP market maker in the course of making a market in those interests or securities on a declared financial market operated in this jurisdiction.
(3) In subsections (1) and (2):
exchange traded fund (or ETF) has the meaning given by subsection 1020B(4D) of the Act.
ETP has the meaning given by subsection 1020B(4D) of the Act.
ETP market maker has the meaning given by subsection 1020B(4D) of the Act.
specified structured product has the meaning given by subsection 1020B(4D) of the Act.
Note: Section 5 of this instrument notionally inserts subsection 1020B(4D) of the Act.
(1) A market maker does not have to comply with subsection 1020AB(3) of the Act to the extent it requires the market maker to give the particulars specified in paragraphs 7.9.100(1)(a) to (c) of the Regulations.
(2) Subsection (1) applies in relation to a sale of a security (the shorted product) or a managed investment product (the shorted product) by the market maker where both of the following are satisfied:
(a) the market maker has issued, acquired or disposed of a financial product (the hedged product), or has agreed to issue, acquire or dispose of a financial product (the hedged product), in the course of making a market for the hedged product; and
(b) the sale of the shorted product is a bona fide transaction to manage, avoid or limit the financial consequences of the dealing or proposed dealing mentioned in paragraph (a).
(3) In this section:
market maker has the meaning given by subsection 1020B(5J).
Note: Section 6 of this instrument notionally inserts subsection 1020B(5J) of the Act.
(1) A seller with a short position in relation to a security or managed investment product that does not exceed the value limit and the volume limit on a day does not have to comply with the following provisions in relation to the short position:
(a) section 1020AB of the Act to the extent that it requires the seller to give the particulars specified in paragraph 7.9.100(1)(d) of the Regulations; or
(b) regulation 7.9.100A of the Regulations.
(2) In this section:
value limit has the meaning given by subsection 1020B(1) of the Act.
volume limit has the meaning given by subsection 1020B(1) of the Act.
Note: Section 16 of this instrument notionally inserts definitions of value limit and volume limit into subsection 1020B(1) of the Act.
Part 7.9 of the Act applies in relation to section 1020B products as if subsection 1020B(1) were modified or varied by inserting the following definitions in the appropriate alphabetical order:
global end calendar time, in relation to a person’s short position, means 11:59 pm on the trading day in the location of the person (or another person within the same corporate group) to whom the transaction giving rise to the short position is accounted for in the balance sheet of the person (or the other person).
nominated time, in relation to a person’s short position, means:
(a) if an opt-out nomination is in force—the global end calendar time;
(b) otherwise—7 pm in Sydney, New South Wales.
opt-out nomination:
(a) an opt-out nomination, in relation to a nominated time for a person’s short position, is in force from a specified date if both of the following apply:
(i) the person has given a written notice to ASIC specifying that the person will be using the global end calendar time from the specified date, provided the specified date is at least 30 days after the date of giving the notice;
(ii) ASIC has not notified the person within 30 days after the date of giving the notice that ASIC objects;
(b) an opt-out nomination, in relation to a nominated time for a person’s short position, ceases to be in force from a specified date if both of the following apply:
(i) the person has given a written notice to ASIC specifying that the person will not be using the global end calendar time from the specified date, provided the specified date is at least 30 days after the date of giving the notice;
(ii) ASIC has not notified the person within 30 days after the date of giving the notice that ASIC objects.
Note: A person in relation to whom an opt-out nomination has ceased to be in force from a specified date under paragraph (b) may give a further written notice under paragraph (a).
reporting day has the meaning given by regulations made for the purposes of Division 5B.
securities lending arrangement has the meaning given by subsection 1020AA(1).
short position has the meaning given by regulations made for the purposes of Division 5B.
value limit: the value limit, in relation to a person for a security or managed investment product that is able to be traded on a financial market, is not exceeded on a day if:
A x B
does not exceed $100,000 where:
A = the person’s short position in relation to the security or product as at the nominated time.
B = either:
(a) the last sale price for the security or product on the financial market on the day (or, if there is no such price on that day, the last sale price on the financial market); or
(b) the price determined and published by the operator of the market after the close of trading for the day as the value of the security or product on the day.
volume limit: the volume limit, in relation to a person for a security or managed investment product that is able to be traded on a financial market, is not exceeded on a day if:
A x 100
B
does not exceed 0.01 where:
A = the person’s short position in relation to the security or product as at the nominated time.
B = the total quantity of securities or products in the same class of securities or products on the day.
(1) Part 7.9 of the Act applies in relation to section 1020B products as if Division 15 of Part 7.9 of the Regulations were modified or varied as follows:
(a) in subregulation 7.9.99(1) omit the definition of reporting day, substitute:
“reporting day, in relation to a short position, means a day that a licensed market that has admitted to quotation the section 1020B product is open for trading.”;
(b) omit subregulation 7.9.99(2) (excluding the heading), substitute:
“(2) In this Division, a short position is a position in relation to a section 1020B product in a listed entity where the quantity of the product which a person, acting in a particular capacity, has is less than the quantity of the product which the person, acting in the same capacity, has an obligation to deliver.
Note: A person may have more than one position in relation to the product on a particular day. For example, a person will have two positions in relation to the product if the person, acting in a particular capacity, has a position and the person, acting in a different capacity, also has a position.”;
(c) omit paragraph 7.9.99(3)(b), substitute:
“(aa) the person holds the product on behalf of another person except where that other person has the sole discretion to decide whether the product will be sold; or
(b) another person is holding the product on the person’s behalf but only where the person has the sole discretion to decide whether the product will be sold; or”;
(d) omit paragraph 7.9.99(4)(b), substitute:
“(b) has a contingent or non-contingent obligation to vest title in a lender under a securities lending arrangement; or”;
(e) after subregulation 7.9.99(4) insert:
“(4A) In subregulation (2), the person has the product or has an obligation to deliver the product only if the person is acting in one or more of the following capacities:
(a) the person is acting on their own behalf; or
(b) the person is acting on behalf of another person except where that other person has the sole discretion to decide whether the product will be sold; or
(c) another person is acting on behalf of the person but only where the person has the sole discretion to decide whether the product will be sold.
(4B) For the purposes of subregulation (2):
(a) subject to paragraph (b), the capacities referred to in each of the paragraphs in subregulation (4A) are taken to be separate capacities;
(b) where a person is acting on their own behalf under paragraph (4A)(a) and another person is acting on the person’s behalf under paragraph (4A)(c), the person is taken to be acting in the same capacity; and
(c) in paragraph (4A)(b), where a person is acting on behalf of a person under an arrangement and is acting on behalf of another person under a different arrangement, the person is taken to be acting in a different capacity for each arrangement.”;
(f) omit subregulation 7.9.99(5) (excluding the heading), substitute:
“(5) Unless the contrary intention appears, a reference in this Division to a time is a reference to the legal time in Sydney, New South Wales.”;
(g) omit paragraph 7.9.100(1)(d), substitute:
“(d) the seller’s short position as at:
(i) where the nominated time is, or corresponds to a time that is, on or before 11:59 pm in Sydney, New South Wales—the nominated time 3 reporting days before the day the particulars must be given under subregulation (4); and
(ii) otherwise—the nominated time 2 reporting days before the day the particulars must be given under subregulation (4).”;
(h) after subregulation 7.9.100(1) insert:
“(1A) For the purposes of paragraph (1)(d), the short position in relation to a section 1020B product is to be calculated by reference to both of the following:
(a) the section 1020B product for which the seller has a presently exercisable and unconditional right to vest in the buyer under a securities lending arrangement;
(b) the section 1020B product for which the seller does not have a presently exercisable and unconditional right to vest in a buyer but who does not have to comply with subsection 1020B(2) of the Act in relation to the sale.”;
(i) in subregulation 7.9.102(1A) after “under section 1020AB of the Act” (twice occurring) insert “(or in accordance with a legislative instrument made under section 1020F of the Act)”;
(2) Part 7.9 of the Act applies in relation to section 1020B products as if section 1020AA were modified or varied by, after subsection (4), inserting:
“(5) For the purposes of applying this Division to a sale of a section 1020B product that is a CGS depository interest, a reference to a listed entity or a listed product is to be read as if there were a listed entity to which that product relates.”;
(3) Part 7.9 of the Act applies in relation to section 1020B products as if section 1020AB were modified or varied by omitting paragraph (3)(a) and substituting:
“(a) give the entity mentioned in subsection (4) particulars specified in the regulations in relation to:
(i) the circumstances mentioned in paragraphs (1)(a), (b) and (c); or
(ii) the sale of a section 1020B product for which the seller does not have a presently exercisable and unconditional right to vest in a buyer but who does not have to comply with subsection 1020B(2) in relation to the sale; and”.
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.
If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.
ad = added or inserted | orig = original |
|
|
am = amended | p = page(s) |
|
|
amdt = amendment | para = paragraph(s)/subparagraph(s) |
|
|
C[x] = Compilation No. x | /sub‑subparagraph(s) |
|
|
ch = Chapter(s) | pres = present |
|
|
cl = clause(s) | prev = previous |
|
|
cont. = continued | (prev…) = previously |
|
|
def = definition(s) | pt = Part(s) |
|
|
Dict = Dictionary | r = regulation(s)/Court rule(s) |
|
|
disallowed = disallowed by Parliament | reloc = relocated |
|
|
div = Division(s) | renum = renumbered |
|
|
exp = expires/expired or ceases/ceased to have | rep = repealed |
|
|
effect | rs = repealed and substituted |
|
|
gaz = gazette | s = section(s)/subsection(s) |
|
|
LA = Legislation Act 2003 | /rule(s)/subrule(s)/order(s)/suborder(s) |
|
|
LIA = Legislative Instruments Act 2003 | sch = Schedule(s) |
|
|
(md not incorp) = misdescribed amendment | SLI = Select Legislative Instrument |
|
|
cannot be given effect | SR = Statutory Rules |
|
|
mod = modified/modification | sub ch = Sub‑Chapter(s) |
|
|
No. = Number(s) | sub div = Subdivision(s) |
|
|
Ord = Ordinance | sub pt = Subpart(s) |
|
|
| underlining = whole or part not |
|
|
| commenced or to be commenced |
|
|
Name | Registration | Commencement | Application, saving and transitional provisions |
ASIC Corporations (Short Selling) Instrument 2018/745 (F2018L01356) | 27/09/2018 | 28/09/2018 | - |
ASIC Corporations (Amendment) Instrument 2019/784 (F2019L01206) | 17/09/2019 | 18/09/2019 | - |
ASIC Corporations (Amendment) Instrument 2021/754 (F2021L01334) | 29/09/2021 | 30/09/2021 | - |
ASIC Corporations (Short Selling) Amendment Instrument 2022/968 (F2022L01582) | 06/12/2022 | 07/12/2022 | - |
ASIC Corporations (Amendment) Instrument 2023/24 (F2023L00059) | 30/01/2023 | 31/01/2023 | - |
ASIC Corporations (Amendment) Instrument 2026/24 (F2026L00061) | 02/02/2026 | 03/02/2026 | - |
Provision affected | How affected |
Section 2 | rep. s48D LA |
Section 5 (heading) | am.2026/24, Sch 1, item [1] |
Section 5 (notional paragraph 1020B(4A)(b)) | rs. 2019/784 am. 2022/968 |
Section 5 (notional subsection 1020B(4A)) | rs.2026/24, Sch 1, item [2] |
Section 5 (notional subsection 1020B(4B)) | am.2026/24, Sch 1, item [3]-[6] |
Section 5 (notional subsection 1020B(4C)) | am.2026/24, Sch 1, item [7]-[8] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of exchange traded fund | am.2026/24, Sch 1, item [9]-[12] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of ETP (or exchange traded product) | ad.2026/24, Sch 1, item [13] |
Section 5 (notional paragraph 1020B(4D)(a)), definition of ETF market maker | am. 2022/968 rs.2026/24, Sch 1, item [14] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of managed fund | rep.2026/24, Sch 1, item [15] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of notice of cessation | am.2026.24, Sch 1, item [16]-[17] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of notice of exclusion | am.2026/24, Sch 1, item [16]-[17] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of notice of reliance | am.2026/24, Sch 1, item [16] and [18]-[20] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of notice of suspension or cancellation | rs.2026/24, Sch 1, item [21] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of precious metal | ad.2026/24, Sch 1, item [22] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of settlement failure limit | am.2026/24, Sch 1, item [23] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of settlement failure notice | am.2026/24, Sch 1, item [23] |
Section 5 (notional paragraph 1020B(4D)(a)) definition of specified structured product | ad.2026/24, Sch 1, item [24] |
Section 5 (notional paragraph 1020B(4D)(b)) | am.2022/968 am.2026/24, Sch 1, item [25] |
Section 6 (notional subparagraph 1020B(5A)(c)(ii)) | am.2022/968 |
Section 6 (notional subparagraph 1020B(5A)(c)(iii)) | ad.2022/968 am.2026/24, Sch 1, item [26]-[27] |
Section 6 (notional paragraph 1020B(5A)(c)) note | rs.2026/24, Sch 1, item [28] |
Section 6 (notional paragraph 1020B(5B)(b)) | am.2022/968 rs.2026/24, Sch 1, item [29] |
Section 6 (notional subsection 1020B(5C)) | am.2022/968
|
Section 6 (notional paragraph 1020B(5C)(d)) | am.2022/968 rs.2026/24, Sch 1, item [30] |
Section 6 (notional subsection 1020B(5J)) | ad.2022/968 |
Section 6 (notional subsection 1020B(5J)) definition of approved ETF | rep.2026/24, Sch 1, item [31] |
Section 6 (notional subsection 1020B(5J)) definition of approved ETP | ad.2026/24, Sch 1, item [32] |
Section 6 (notional subsection 1020B(5J)) definition of approved ETO | am.2026/24, Sch 1, item [33] |
Section 6 (notional subsection 1020B(5J)) definition of ETF | rep.2026/24, Sch 1, item [34] |
Section 6 (notional subsection 1020B(5J)) definition of ETP | ad.2026/24, Sch 1, item [35] |
Subsection 8(4) (definition of exchange traded option) | am.2022/968
|
Subsection 10(2) | am.2026/24, Sch 1, item [36] |
Subsection 10(2), note | rs.2026/24, Sch 1, item [37] |
Section 11 (notional subsection 1020B(7B) note
| am.2022/968 |
Section 11 (notional subparagraph 1020B(7C)(a)(ii)) | am.2022/968
|
Section 11 (notional subparagraph 1020B(7D)(a)(iii)) | am.2022/968 |
Section 11 (notional paragraph 1020B(7F)(b)) definition of deferred settlement trading arrangements | am.2026/24, Sch 1, item [38]-[40] |
Section 11 (notional paragraph 1020B(7F)(b)) definition of deferred settlement trading period | am.2026/24, Sch 1, item [38]-[39] |
Section 11 (notional paragraph 1020B(7F)(b)) definition of listed corporation | rep.2026/24, Sch 1, item [41] |
Section 11 (notional paragraph 1020B(7F)(b)) definition of listing body | rs.2026/24, Sch 1, item [42] |
Section 11 (notional paragraph 1020B(7F)(b)) definition of listing scheme | rs. 2026/24, Sch 1, item [43] |
Section 11 (notional paragraph 1020B(7F)(b)) paragraph (b) of definition of public offer | ad.2022/968 |
Section 11 (notional paragraph 1020B(7F)(b)), definition of public offer | am.2026/24, Sch 1, item [44]-[45] |
Section 11 (notional paragraph 1020B(7H)(b)) | am. 2022/968 (Sch 1 item 15 md not incorp) |
Section 11 (notional subsection 1020B(7H)) | rs.2023/24 |
Section 11 (notional subsection 1020B(7H) note) | am.2022/968 |
Section 11 (notional subsection 1020B(7J)) definition of deferred settlement trading arrangements
| am.2026/24, Sch 1, item [46]-[48] |
Section 11 (notional subsection 1020B(7J)) definition of deferred settlement trading period | am.2026/24, Sch 1, item [46]-[47] |
Paragraph 12(1)(a) | am.2026/24, Sch 1, item [49] |
Section 13 (heading) | am.2026/24, Sch 1, item [50] |
Subsection 13(1) | am.2026/24, Sch 1, item [51] |
Subsection 13(2) | rs.2019/784 am.2022/968 rs.2026/24, Sch 1, item [52] |
Subsection 13(3), definition of ETF market maker | am.2026/24, Sch 1, item [53]
|
Subsection 13(3) definition of ETP | ad.2026/24, Sch 1, item [54] |
Subsection 13(3) definition of specified structured products | ad.2026/24, Sch 1, item [54]
|
Subsection 13(3) definition of managed fund | rep.2026/24, Sch 1, item [55] |
Part 6 | rep.2021/754
|